Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II Study With Oral Panobinostat Maintenance Therapy Following Allogeneic Stem Cell Transplantation in Patients With High Risk MDS or AML (PANOBEST)

NCT01451268 is registered in ClinicalTrials.gov with Johann Wolfgang Goethe University Hospital as lead sponsor.

NCT NCT01451268
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01451268 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II Study With Oral Panobinostat Maintenance Therapy Following Allogeneic Stem Cell Transplantation in Patients With High Risk MDS or AML (PANOBEST)
Lead sponsor
Johann Wolfgang Goethe University Hospital
Phase
Phase 1/2
Overall status
Unknown status
Start date
January 31, 2011
Completion date
April 30, 2018
Enrollment
62 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia, myelodysplastic syndrome